Assessing Cardiovascular Target Attainment in Type 2 Diabetes Mellitus Patients in Tertiary Diabetes Center in Romania

Introduction: Type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) share a bidirectional link, and the innovative antidiabetic molecules GLP-1 Ras and SGLT-2is have proven cardiac and renal benefits, respectively. This study aimed to evaluate CV risk categories, along with lipid-lowering...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Pharmaceuticals (Basel, Switzerland) Ročník 17; číslo 9; s. 1249
Hlavní autori:	Salmen, Teodor, Pietrosel, Valeria-Anca, Reurean-Pintilei, Delia, Iancu, Mihaela Adela, Cimpeanu, Radu Cristian, Bica, Ioana-Cristina, Dumitriu-Stan, Roxana-Ioana, Potcovaru, Claudia-Gabriela, Salmen, Bianca-Margareta, Diaconu, Camelia-Cristina, Cretoiu, Sanda Maria, Stoian, Anca Pantea
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland MDPI AG 01.09.2024 MDPI
Predmet:	Antidiabetics Atherosclerosis cardio-renal protection cardiovascular disease Cardiovascular diseases Care and treatment Complications and side effects Demographic aspects Diabetes Diabetic neuropathy Diagnosis Disease Exercise Fatalities Glucose LDL-cholesterol Lipids Metabolic disorders Mortality Oxidative stress Patients risk Risk factors statin Statins Type 2 diabetes type 2 diabetes mellitus Weight control Romania LDL-cholesterol cardiovascular disease statin type 2 diabetes mellitus risk cardio-renal protection sodium-glucose co-transporter-2 inhibitors glucagon-like peptide-1 receptor agonists
ISSN:	1424-8247, 1424-8247
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!